---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-005710"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-02-18T23:59:59+00:00"
generated_at: "2026-06-27T06:43:15.390896+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Board member and Vice Chair Robert G. Finizio resigns from TherapeuticsMD effective immediately

## Summary
- Robert G. Finizio resigned from the board of directors and as Vice Chair on February 17, 2022.
- Resignation is not due to any disagreement with the company's operations, policies, or practices.
- No replacement has been announced in the filing.

## SEC filing metadata
- accession: 0001564590-22-005710
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-02-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000156459022005710/0001564590-22-005710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000156459022005710/txmd-8k_20220217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-005710
- JSON: https://secwatch.observer/filing/0001564590-22-005710.json
- Plain text: https://secwatch.observer/filing/0001564590-22-005710.txt

## Key facts
- Executive change
  Robert G. Finizio resigned as Vice Chair at TherapeuticsMD, Inc..
  - Action: resigned
  - Role: Vice Chair
  source text: On February 17, 2022, Mr. Robert G. Finizio notified TherapeuticsMD, Inc., a Nevada corporation (the “Company”), of his decision to resign from the board of directors of the Company and as Vice Chair thereof, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000156459022005710/0001564590-22-005710-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.